Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/24/25 21:05 | 10/24/25 | ADMA | Health | BioPrd | Biological Products, (No Diag | Grossman Adam S | NJ | DO | P,CEO,,I | 11 | S.dm | -16,144 | 17.12 | 0 | -943 | 3,806 | D | |||||||||||||||
6/16/25 21:00 | 6/12/25 | ADMA | Health | BioPrd | Biological Products, (No Diag | Elms Steve | NY | D | 1 | S.dm | -8,829 | 20.74 | 0 | -426 | 2,119 | M | ||||||||||||||||
6/11/25 21:00 | 6/9/25 | ADMA | Health | BioPrd | Biological Products, (No Diag | Guiheen Lawrence P. | NJ | D | 3 | S.dm | -768 | 20.21 | 0 | -38 | 166 | D | ||||||||||||||||
6/10/25 21:00 | 6/9/25 | ADMA | Health | BioPrd | Biological Products, (No Diag | Grossman Jerrold B | NJ | D | 2 | S.d | -2,577 | 17.55 | 0 | -147 | 571 | D | ||||||||||||||||
11/22/24 21:05 | 11/22/24 | ADMA | Health | BioPrd | Biological Products, (No Diag | Tade Brad L. | FL | O | CFO,Trea | 1 | S | -317 | 21.15 | 0 | -15 | 199 | D | |||||||||||||||
8/30/24 21:05 | 8/30/24 | ADMA | Health | BioPrd | Biological Products, (No Diag | Kestenberg-Messina Kaitlin M. | FL | O | COO,SVP, | 1 | S.d | -408 | 16.90 | 0 | -24 | 449 | D | |||||||||||||||
8/27/24 21:00 | 8/23/24 | ADMA | Health | BioPrd | Biological Products, (No Diag | Kwon Young | NJ | D | 1 | S | -1,096 | 18.26 | 0 | -60 | 241 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |